NOBERA PHARMA, S.L.;ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES S.A.
发明人:
申请号：
IL21583111
公开号：
IL215831D0
申请日:
2011.10.23
申请国别(地区):
IL
年份:
2012
代理人:
摘要：
Use of allopurinol or a pharmaceutically acceptable salt thereof for the treatment or prevention of Hand Foot Skin Reaction (HFSR) induced by Multitargeted Kinase (MKI) therapy. The allopurinol or its salt is administered topically to the affected areas, palms and soles, preferably in the form of a cream.
